Zura Bio Ltd.Preferred / convertible

13F holders, Q2 2024 (June 30)
14holders +1
3new positions
2sold out
$0.51avg. 13F price*

At the end of Q2 2024, 14 institutions reported holding Zura Bio Ltd. in their 13F filings, up 1 from Q1 2024. 3 opened new positions and 2 sold out. The largest holders were Meteora Capital, LLC ($211K), Boothbay Fund Management, LLC ($185K) and Boussard & Gavaudan Investment Management LLP ($86K).

Company
Zura Bio Ltd.
CUSIP
G9TY5A119
Latest filing quarter
Q2 2024

History

Number of 13F holders

051015 Q1 2024: 13Q1 2024Q2 2024: 14Q2 2024

Total Exit/New Position Q1 2024 → Q2 2024

InstitutionsTotal Value
New Positions3$273K
Exits2$25K

All 13F filers, Q1 2024 → Q2 2024: 742,053 shares bought and 115,250 shares sold, net +626,803 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 14 holders

Meteora Capital, LLC — Add +442.4% 527,362 $211K
Boothbay Fund Management, LLC — New 52,926 $185K
Boussard & Gavaudan Investment Management LLP — No change 187,500 $86K
Calamos Advisors LLC — New 200,000 $80K
Hudson Bay Capital Management LP — Reduce -0.2% 199,575 $80K
Kim, LLC — No change 125,000 $50K
Whitebox Advisors LLC — No change 75,000 $30K
Two Sigma Investments, LP — Add +207.1% 66,017 $26K
Walleye Capital LLC — No change 56,608 $23K
Clear Street LLC — Reduce -0.0% 45,663 $18K
Walleye Trading LLC — No change 31,842 $13K
Privium Fund Management B.V. — New 14,067 $8K
Warberg Asset Management LLC — Reduce -50.0% 12,909 $5K
Wolverine Asset Management LLC — Add +126.0% 739 $295

"% of holder's portfolio" is ZURA BIO LTD's weight in each manager's 13F, not the share of Zura Bio Ltd. the manager owns.